New-Onset Diabetes Mellitus Among Parkinsonian Patients Treated with Long-term Quetiapine

New-Onset Diabetes Mellitus Among Parkinsonian Patients Treated with Long-term Quetiapine

Atypical antipsychotics (AA) are commonly used to manage drug-induced psychosis (DIP) in parkinsonian patients. In the treatment of schizophrenia, AA’s have been associated with increasing reports of new-onset diabetes mellitus (DM). This study examined the risk of developing new-onset DM among park...

Full description

Bibliographic Details
Main Authors: Hubert H. Fernandez, Katie M. McCown, Janet Romrell, Martha E. Trieschmann, Joseph H. Friedman, Charles E. Jacobson IV, Michael S. Okun
Format: Article
Language:English
Published: AboutScience Srl 2008-01-01
Series:Drug Target Insights
Subjects:
quetiapine
diabetes
atypical antipsychotic
parkinson’s disease
Online Access:http://la-press.com/article.php?article_id=630

Similar Items

Similar Items